TY - JOUR
T1 - Biomechanical modeling of transcatheter aortic valve replacement in a stenotic bicuspid aortic valve
T2 - deployments and paravalvular leakage
AU - Lavon, Karin
AU - Marom, Gil
AU - Bianchi, Matteo
AU - Halevi, Rotem
AU - Hamdan, Ashraf
AU - Morany, Adi
AU - Raanani, Ehud
AU - Bluestein, Danny
AU - Haj-Ali, Rami
N1 - Publisher Copyright:
© 2019, International Federation for Medical and Biological Engineering.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Calcific aortic valve disease (CAVD) is characterized by stiffened aortic valve leaflets. Bicuspid aortic valve (BAV) is the most common congenital heart disease. Transcatheter aortic valve replacement (TAVR) is a treatment approach for CAVD where a stent with mounted bioprosthetic valve is deployed on the stenotic valve. Performing TAVR in calcified BAV patients may be associated with post-procedural complications due to the BAV asymmetrical structure. This study aims to develop refined computational models simulating the deployments of Evolut R and PRO TAVR devices in a representative calcified BAV. The paravalvular leakage (PVL) was also calculated by computational fluid dynamics simulations. Computed tomography scan of severely stenotic BAV patient was acquired. The 3D calcium deposits were generated and embedded inside a parametric model of the BAV. Deployments of the Evolut R and PRO inside the calcified BAV were simulated in five bioprosthesis leaflet orientations. The hypothesis of asymmetric and elliptic stent deployment was confirmed. Positioning the bioprosthesis commissures aligned with the native commissures yielded the lowest PVL (15.7 vs. 29.5 mL/beat). The Evolut PRO reduced the PVL in half compared with the Evolut R (15.7 vs. 28.7 mL/beat). The proposed biomechanical computational model could optimize future TAVR treatment in BAV patients.
AB - Calcific aortic valve disease (CAVD) is characterized by stiffened aortic valve leaflets. Bicuspid aortic valve (BAV) is the most common congenital heart disease. Transcatheter aortic valve replacement (TAVR) is a treatment approach for CAVD where a stent with mounted bioprosthetic valve is deployed on the stenotic valve. Performing TAVR in calcified BAV patients may be associated with post-procedural complications due to the BAV asymmetrical structure. This study aims to develop refined computational models simulating the deployments of Evolut R and PRO TAVR devices in a representative calcified BAV. The paravalvular leakage (PVL) was also calculated by computational fluid dynamics simulations. Computed tomography scan of severely stenotic BAV patient was acquired. The 3D calcium deposits were generated and embedded inside a parametric model of the BAV. Deployments of the Evolut R and PRO inside the calcified BAV were simulated in five bioprosthesis leaflet orientations. The hypothesis of asymmetric and elliptic stent deployment was confirmed. Positioning the bioprosthesis commissures aligned with the native commissures yielded the lowest PVL (15.7 vs. 29.5 mL/beat). The Evolut PRO reduced the PVL in half compared with the Evolut R (15.7 vs. 28.7 mL/beat). The proposed biomechanical computational model could optimize future TAVR treatment in BAV patients.
KW - Bicuspid aortic valve
KW - Computational fluid dynamics
KW - Finite element
KW - Paravalvular leakage
KW - Transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85073583772&partnerID=8YFLogxK
U2 - 10.1007/s11517-019-02012-y
DO - 10.1007/s11517-019-02012-y
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:85073583772
SN - 0140-0118
VL - 57
SP - 2129
EP - 2143
JO - Medical and Biological Engineering and Computing
JF - Medical and Biological Engineering and Computing
IS - 10
ER -